Health Canada
- Status: approved
🇨🇦 recombinant B-type, natriuretic peptide in Canada
recombinant B-type, natriuretic peptide (recombinant B-type, natriuretic peptide) regulatory status in Canada.
Marketing authorisation
recombinant B-type, natriuretic peptide in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in Canada
Frequently asked questions
Is recombinant B-type, natriuretic peptide approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for recombinant B-type, natriuretic peptide in Canada?
University of Texas Southwestern Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.